|
1
|
Mandey SH, Schneiders MS, Koster J and
Waterham HR: Mutational spectrum and genotype-phenotype
correlations in mevalonate kinase deficiency. Hum Mutat.
27:796–802. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Celec P and Behuliak M: The lack of
non-steroid isoprenoids causes oxidative stress in patients with
mevalonic aciduria. Med Hypotheses. 70:938–940. 2008. View Article : Google Scholar
|
|
3
|
Marcuzzi A, Decorti G, Pontillo A, Ventura
A and Tommasini A: Decreased cholesterol levels reflect a
consumption of anti-inflammatory isoprenoids associated with an
impaired control of inflammation in a mouse model of mevalonate
kinase deficiency. Inflamm Res. 59:335–338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Drenth JP, Cuisset L, Grateau G, Vasseur
C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW
and Delpech M: Mutations in the gene encoding mevalonate kinase
cause hyper-IgD and periodic fever syndrome. International
Hyper-IgD Study Group. Nat Genet. 22:178–181. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Houten SM, Wanders RJ and Waterham HR:
Biochemical and genetic aspects of mevalonate kinase and its
deficiency. Biochim Biophys Acta. 1529:19–32. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haas D and Hoffmann GF: Mevalonate kinase
deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D
syndrome. Orphanet J Rare Dis. 1:132006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Caso F, Rigante D, Vitale A, Lucherini OM,
Costa L, Atteno M, Compagnone A, Caso P, Frediani B, Galeazzi M,
Punzi L and Cantarini L: Monogenic autoinflammatory syndromes:
state of the art on genetic, clinical, and therapeutic issues. Int
J Rheumatol. 2013:5137822013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Almeida de Jesus A and Goldbach-Mansky R:
Monogenic auto-inflammatory diseases: concept and clinical
manifestations. Clin Immunol. 147:155–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Frenkel J, Houten SM, Waterham HR, Wanders
RJ, Rijkers GT, Kimpen JL, Duran R, Poll-The BT and Kuis W:
Mevalonate kinase deficiency and Dutch type periodic fever. Clin
Exp Rheumatol. 18:525–532. 2000.PubMed/NCBI
|
|
10
|
Prietsch V, Mayatepek E, Krastel H, Haas
D, Zundel D, Waterham HR, Wanders RJ, Gibson KM and Hoffmann GF:
Mevalonate Kinase deficiency: enlarging the clinical and
biochemical spectrum. Pediatrics. 111:258–261. 2013. View Article : Google Scholar
|
|
11
|
Vuch J, Marcuzzi A, Bianco AM, Tommasini
A, Zanin V and Crovella S: Evolutionary hypothesis of the
Mevalonate Kinase Deficiency. Med Hypotheses. 80:67–69. 2013.
View Article : Google Scholar
|
|
12
|
Stabile A, Compagnone A, Napodano S,
Raffaele CG, Patti M and Rigante D: Mevalonate kinase genotype in
children with recurrent fevers and high serum IgD level. Rheumatol
Int. 33:3039–3042. 2013. View Article : Google Scholar
|
|
13
|
D'Osualdo A, Picco P, Caroli F, Gattorno
M, Giacchino R, Fortini P, Corona F, Tommasini A, Salvi G, Specchia
F, et al: MVK mutations and associated clinical features in Italian
patients affected with autoinflammatory disorders and recurrent
fever. Eur J Hum Genet. 13:314–320. 2005. View Article : Google Scholar
|
|
14
|
Shendi HM, Walsh D and Edgar JD:
Etanercept and anakinra can prolong febrile episodes in patients
with hyper-immunoglobulin D and periodic fever syndrome. Rheumatol
Int. 32:249–251. 2012. View Article : Google Scholar
|
|
15
|
Uhlig HHL: Monogenic diseases associated
with intestinal inflammation: implications for the understanding of
inflammatory bowel disease. Gut. 62:1795–1805. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Levy M, Arion A, Berrebi D, Cuisset L,
Jeanne-Pasquier C, Bader-Meunier B and Jung C: Severe early-onset
colitis revealing mevalonate kinase deficiency. Pediatrics.
132:e779–e783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bianco AM, Girardelli M, Vozzi D, Crovella
S, Kleiner G and Marcuzzi A: Mevalonate kinase deficiency and IBD:
shared genetic background. Gut. 63:1367–1368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Siemiatkowska AM, Van den Born LI, Van
Hagen PM, Stoffels M, Neveling K, Henkes A, Kipping-Geertsema M,
Hoefsloot LH, Hoyng CB, Simon A, et al: Mutations in the mevalonate
kinase (MVK) gene cause nonsyndromic retinitis pigmentosa.
Ophthalmology. 120:2697–2705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Balgobind B, Wittebol-Post D and Frenkel
J: Retinitis pigmentosa in mevalonate kinase deficiency. J Inherit
Metab Dis. 28:1143–1145. 2005. View Article : Google Scholar
|
|
20
|
Tricarico PM, Kleiner G, Valencic E,
Campisciano G, Girardelli M, Crovella S, Knowles A and Marcuzzi A:
Block of the mevalonate pathway triggers oxidative and inflammatory
molecular mechanisms modulated by exogenous isoprenoid compounds.
Int J Mol Sci. 15:6843–6856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marcuzzi A, Zanin V, Piscianz E, Tricarico
PM, Vuch J, Girardelli M, Monasta L, Bianco AM and Crovella S:
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a
neuroblastoma cell line. Int J Dev Neurosci. 30:451–456. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marcuzzi A, De Leo L, Decorti G, Crovella
S, Tommasini A and Pontillo A: The farnesyltransferase inhibitors
tipifarnib and lonafarnib inhibit cytokines secretion in a cellular
model of mevalonate kinase deficiency. Pediatr Res. 70:78–82. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simon A: Cholesterol metabolism and
immunity. N Engl J Med. 371:1933–1935. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reboldi A, Dang EV, McDonald JG, Liang G,
Russell DW and Cyster JG: Inflammation. 25-Hydroxycholesterol
suppresses interleukin-1-driven inflammation downstream of type I
interferon. Science. 345:679–684. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adzhubei I, Jordan DM and Sunyaev SR:
Predicting functional effect of human missense mutations using
PolyPhen-2. Curr Protoc Hum Genet Chapter. 7:Unit7.202013.
|
|
26
|
Schwarz JM, Rödelsperger C, Schuelke M and
Seelow D: Mutation Taster evaluates disease-causing potential of
sequence alterations. Nat Methods. 7:575–576. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Jian X and Boerwinkle E: dbNSFP
v2.0: A database of human non-synonymous SNVs and their functional
predictions and annotations. Hum Mutat. 34:E2393–E2402. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pollard KS, Hubisz MJ, Rosenbloom KR and
Siepel A: Detection of nonneutral substitution rates on mammalian
phylogenies. Genome Res. 20:110–121. 2010. View Article : Google Scholar :
|
|
29
|
Kimura M: The neutral theory of molecular
evolution: a review of recent evidence. Jpn J Genet. 66:367–386.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Danecek P, Auton A, Abecasis G, Albers CA,
Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST,
et al: The variant call format and VCFtools. Bioinformatics.
27:2156–2158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang K, Li M and Hakonarson H: ANNOVAR:
Functional annotation of genetic variants from high-throughput
sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shoemaker JD and Elliott WH: Automated
screening of urine samples for carbohydrates, organic and amino
acids after treatment with urease. J Chromatogr. 562:125–138. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Simon A, Kremer HP, Wevers RA, Scheffer H,
De Jong JG, Van Der Meer JW and Drenth JP: Mevalonate kinase
deficiency: Evidence for a phenotypic continuum. Neurology.
62:994–997. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Opaliński Ł, Veenhuis M and van der Klei
IJ: Peroxisomes: membrane events accompanying peroxisome
proliferation. Int J Biochem Cell Biol. 43:847–851. 2011.
View Article : Google Scholar
|
|
35
|
Li X and Gould SJ: PEX11 promotes
peroxisome division independently of peroxisome metabolism. J Cell
Biol. 156:643–651. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wanders RJ and Waterham HR: Biochemistry
of mammalian peroxisomes revisited. Annu Rev Biochem. 75:295–332.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Steinberg SJ, Dodt G, Raymond GV,
Braverman NE, Moser AB and Moser HW: Peroxisome biogenesis
disorders. Biochim Biophys Acta. 1763:1733–1748. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ebberink MS, Koster J, Visser G, Spronsen
Fv, Stolte-Dijkstra I, Smit GP, Fock JM, Kemp S, Wanders RJ and
Waterham HR: A novel defect of peroxisome division due to a
homozygous non-sense mutation in the PEX11β gene. J Med Genet.
49:307–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wiemer EA, Wenzel T, Deerinck TJ, Ellisman
MH and Subramani S: Visualization of the peroxisomal compartment in
living mammalian cells: dynamic behavior and association with
microtubules. J Cell Biol. 136:71–80. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Koch J, Pranjic K, Huber A, Ellinger A,
Hartig A, Kragler F and Brocard C: PEX11 family members are
membrane elongation factors that coordinate peroxisome
proliferation and maintenance. J Cell Sci. 123:3389–3400. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Torseth K, Doseth B, Hagen L, Olaisen C,
Liabakk NB, Græsmann H, Durandy A, Otterlei M, Krokan HE, Kavli B
and Slupphaug G: The UNG2 Arg88Cys variant abrogates RPA-mediated
recruitment of UNG2 to single-stranded DNA. DNA Repair (Amst).
11:559–569. 2012. View Article : Google Scholar
|
|
42
|
Al-Saud BK, Al-Sum Z, Alassiri H,
Al-Ghonaium A, Al-Muhsen S, Al-Dhekri H, Arnaout R, Alsmadi O,
Borrero E, Abu-Staiteh A, Rawas F, Al-Mousa H and Hawwari A:
Clinical, immunological, and molecular characterization of
hyper-IgM syndrome due to CD40 deficiency in eleven patients. J
Clin Immunol. 33:1325–1335. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Imai K, Slupphaug G, Lee WI, Revy P,
Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, et
al: Human uracil-DNA glycosylase deficiency associated with
profoundly impaired immunoglobulin class-switch recombination. Nat
Immunol. 4:1023–1028. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Drenth JP, Haagsma CJ and van der Meer JW:
Hyperimmunoglobulinemia D and periodic fever syndrome The clinical
spectrum in a series of 50 patients International Hyper-IgD Study
Group. Medicine (Baltimore). 73:133–144. 1994. View Article : Google Scholar
|
|
45
|
Klasen IS, Göertz JH, van de Wiel GA,
Weemaes CM, van der Meer JW and Drenth JP: Hyper-immunoglobulin A
in the hyper-immunoglobulinemia D syndrome. Clin Diagn Lab Immunol.
8:58–61. 2001.PubMed/NCBI
|
|
46
|
Moura R, Tricarico PM, Campos Coelho AV
and Crovella S: GRID2 a novel gene possibly associated with
mevalonate kinase deficiency. Rheumatol Int. 35:657–659. 2015.
View Article : Google Scholar
|
